Investor Stock List
Ranked #4,014 of 8,699 institutional investors

venBio Partners LLC

San Francisco, CA

$431M
US stock portfolio at live prices · today −$4.3M (−1.00%)
Market closed. Prices as of Nov 20, 7:41 AM ET
Value at quarter end (Q3 2026)
$496M
Change from Q2 2026
−$23.5M (−4.52%)
Positions
8 · 3 new, 1 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$141M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PBLS 33.8%ATTO 15.1%QUIT 8.06%ALMS 4.21%ALXO 3.05%
StockSharesValue, live% of portfoliovs Q2 2026
PBLS Parabilis Medicines, Inc.5,266,697$145M33.8%Unchanged
ATTO Attovia Therapeutics, Inc.4,181,366$65.1M15.1%New
QUIT Achieve Life Sciences, Inc.5,914,720$34.7M8.06%Unchanged
ALMS Alumis Inc.4,191,408$18.1M4.21%Reduced −7%
ALXO ALX Oncology Holdings Inc.12,884,638$13.1M3.05%Unchanged
YARW Yarrow Bioscience, Inc.554,769$7.9M1.83%New
LYEL Lyell Immunopharma, Inc.337,697$4.6M1.06%Unchanged
LSTA Lisata Therapeutics, Inc.156,460$142K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
HRMY Harmony Biosciences Holdings, Inc.472,194$15.6M